MALT1 and autoimmune disease: Status of t(11;18)/API2-MALT1 [16,18], MIB-1 status [19], age [20], presence of an autoimmune disease [21,22], and gastric location [23,24,25] have been studied as predictive factors for H. pylori eradication therapy.